Castle Biosciences Inc Net Asset Quality Index
Castle Biosciences Inc net asset quality index. Castle Biosciences Inc (CSTL) has a Net Asset Quality Index of 83.8% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $561.18 Million minus total liabilities of $91.15 Million yields net assets of $470.03 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check how high is Castle Biosciences Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Castle Biosciences Inc (2017–2025)
Net asset quality index of Castle Biosciences Inc from 2017 to 2025. This chart shows how Castle Biosciences Inc's Net Asset Quality Index has evolved across 9 annual periods from 2017 to 2025. As of June 2026, the index stands at 83.8%, representing net assets of $470.03 Million against total assets of $561.18 Million USD. See CSTL total equity for net asset value and shareholders' equity analysis.
Castle Biosciences Inc Net Asset Quality Index by Year (2017–2025)
Castle Biosciences Inc net asset quality index by year from 2017 to 2025. The table below presents the year-by-year Net Asset Quality Index for Castle Biosciences Inc from 2017 to 2025, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Castle Biosciences Inc.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 81.4% | $470.87 Million | $578.56 Million | $107.68 Million | ▼ -4.4 pp |
| 2024 | 85.8% | $455.83 Million | $531.24 Million | $75.40 Million | ▼ -0.5 pp |
| 2023 | 86.3% | $391.27 Million | $453.34 Million | $62.07 Million | ▼ -2.9 pp |
| 2022 | 89.2% | $399.15 Million | $447.33 Million | $48.18 Million | ▲ +0.2 pp |
| 2021 | 89.0% | $411.74 Million | $462.57 Million | $50.83 Million | ▼ -5.6 pp |
| 2020 | 94.6% | $415.69 Million | $439.33 Million | $23.64 Million | ▲ +23.5 pp |
| 2019 | 71.1% | $85.11 Million | $119.75 Million | $34.63 Million | ▲ +116.0 pp |
| 2018 | -44.9% | $-10.07 Million | $22.40 Million | $32.47 Million | ▲ +100.4 pp |
| 2017 | -145.3% | $-14.27 Million | $9.82 Million | $24.09 Million | — |